The Oral Testosterone Revolution: How KYZATREX Is Changing the Future of TRT

madman · 2025-11-11T17:47:17-0600

Shalin Shah is the founder & CEO of Marius Pharmaceuticals, the company that partnered with $HIMS to launch oral testosterone (KYZATREX). We discuss how the partnership came about, the benefits of teaming up with HIMS, and the future of TRT.

Chapters

(00:41) Origin of the partnership
(02:55) Benefits of partnering with HIMS
(04:14) Deal shape and exclusivity
(06:51) How KYZATREX will sit alongside compounded meds on the HIMS platform
(09:22) Will KYZATREX be personalized?
(16:07) TRT as a schedule 3 substance
(21:39) Gearing up for 2026 launch of KYZATREX
(22:40) Future of TRT market
(27:29) Peptides
(29:44) Testosterone for females

madman · 2025-11-11T17:48:16-0600

Thread 'FDA-Approved Oral Testosterone Therapy KYZATREX® Now on Hims & Hers: Marius Pharmaceuticals Expands Access for Men’s Health & HRT'

Sep 10, 2025

Marius Pharmaceuticals and Hims & Hers™ Collaborate to Expand Access to KYZATREX® (testosterone undecanoate) CIII Capsules, the First FDA-Approved Oral Testosterone Therapy Offered on the Hims & Hers Platform

RALEIGH, N.C., Sept. 10, 2025 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals, Inc. today announced a collaboration with Hims & Hers™, one of the largest...

www.globenewswire.com

RALEIGH, N.C., Sept. 10, 2025 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals, Inc. today announced a collaboration with Hims & Hers™, one of the largest digital health platforms for men, to make KYZATREX®, an FDA-approved oral testosterone replacement therapy for adult men with low or no testosterone levels due to...